These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26924035)

  • 1. An unusual manifestation in a patient with Neurofibromatosis type 1.
    Miraglia E; Iacovino C; Cantisani C; Calvieri S; Giustini S
    G Ital Dermatol Venereol; 2016 Feb; 151(1):129-30. PubMed ID: 26924035
    [No Abstract]   [Full Text] [Related]  

  • 2. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
    Schierl M; Foedinger D; Geissler K; Rappersberger K; Feldmann R
    Eur J Dermatol; 2008; 18(6):717-8. PubMed ID: 19049939
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia.
    Feugier P; Aurran T; Mahé B; Letestu R; Nguyen-Khac F; Cazin B; Tournilhac O; Maisonneuve H; Casasnovas O; Delmer A; Leblond V; Royer B; Corront B; Chevret S; Delépine R; Vaudaux S; Van Den Neste E; Béné MC; Cymbalista F; Ross-Weil D; Leprêtre S
    Haematologica; 2018 Jul; 103(7):e304-e306. PubMed ID: 29545348
    [No Abstract]   [Full Text] [Related]  

  • 4. An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia.
    Soon AK; Chan TY
    Can J Ophthalmol; 2015 Aug; 50(4):e60-3. PubMed ID: 26257236
    [No Abstract]   [Full Text] [Related]  

  • 5. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T; Schuster SJ
    J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.
    De Padua L; Laurenti L; Falcucci P; D'arena G; Vannata B; Innocenti I; Autore F; Piccirillo N; Za T; Marietti S; Efremov DG; Sica S
    Ann Hematol; 2014 Jul; 93(7):1261-2. PubMed ID: 24306088
    [No Abstract]   [Full Text] [Related]  

  • 7. Unusual leukemia presentations. Case 3. Type I IgGlambda cryoglobulinemia associated with chronic lymphocytic leukemia.
    Mantha S; Jacobs MI; Savage DG
    J Clin Oncol; 2005 Aug; 23(24):5841-3. PubMed ID: 16110039
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
    Cervigón I; Palomo A; Torres-Iglesias LM; Solano F; Zapata AM
    Actas Dermosifiliogr; 2011 May; 102(4):305-7. PubMed ID: 21354544
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience.
    Herishanu Y; Goldschmidt N; Bairey O; Ruchlemer R; Fineman R; Rahimi-Levene N; Shvidel L; Tadmor T; Ariel A; Braester A; Shapiro M; Joffe E; Polliack A;
    Haematologica; 2015 May; 100(5):662-9. PubMed ID: 25661442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late reactivation of occult hepatitis B virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen.
    Dominguez N; Manzano ML; Muñoz R; Martin A; Fernandez I; Castellano G
    Leuk Lymphoma; 2015 Apr; 56(4):1160-3. PubMed ID: 25115508
    [No Abstract]   [Full Text] [Related]  

  • 11. Point: Does Chemoimmunotherapy Still Have a Role in CLL? Chemoimmunotherapy With FCR Is Still an Important Option in CLL.
    Thompson PA; Tam CS
    Oncology (Williston Park); 2018 Jun; 32(6):291-2, 294-6. PubMed ID: 29940059
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal failure secondary to leukemic infiltration of kidneys in CLL--a case report and review of literature.
    Uprety D; Peterson A; Shah BK
    Ann Hematol; 2013 Jan; 92(2):271-3. PubMed ID: 22875063
    [No Abstract]   [Full Text] [Related]  

  • 13. Does FCR have the potential to cure a subgroup of patients with chronic lymphocytic leukemia?
    Wierda WG
    Clin Adv Hematol Oncol; 2019 Apr; 17(4):214-216. PubMed ID: 31188811
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab].
    Gu WJ; Xu W; Qian SX; Wu YJ; Hong M; Chen LJ; Wu HX; Lu H; Qiu HX; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):938-42. PubMed ID: 18718095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab].
    Tsukasaki K
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():632-5. PubMed ID: 25831837
    [No Abstract]   [Full Text] [Related]  

  • 16. Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemia.
    Chae YK; Trinh L; Jain P; Wang X; Rozovski U; Wierda WG; Keating MJ; Estrov Z
    Blood; 2014 Feb; 123(9):1424-6. PubMed ID: 24578497
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.
    Orlandi EM; Baldanti F; Citro A; Pochintesta L; Gatti M; Lazzarino M
    Haematologica; 2008 Nov; 93(11):1758-60. PubMed ID: 18790800
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing the way we think about chronic lymphocytic leukemia.
    Lin TS; Grever MR; Byrd JC
    J Clin Oncol; 2005 Jun; 23(18):4009-12. PubMed ID: 15767640
    [No Abstract]   [Full Text] [Related]  

  • 19. In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia.
    Tam CS
    Intern Med J; 2009 Dec; 39(12):858-9. PubMed ID: 20233254
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL.
    Desmond R; Lynch K; Gleeson M; Farrell M; Murphy P
    Am J Hematol; 2010 Aug; 85(8):607. PubMed ID: 20029990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.